Latest EPO Stories
Sofics DTSCR patent prevails over prior art in EPO opposition MUNICH, NEUBIBERG, Germany and GISTEL, Belgium, Oct.
JENA, Germany, July 23, 2014 /PRNewswire/ -- Occlutech, a leading European developer of minimally invasive implants for therapy in structural heart disease, today announced
LONDON, July 21, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
Network Misrepresentations, Enrollment Delays, and Customer Service Practices Violate California Law SANTA MONICA, Calif., July 9, 2014 /PRNewswire-USNewswire/ -- Blue Cross vastly misrepresented
LONDON and MUNICH, April 29, 2014 /PRNewswire/ -- - Toumazou developed game-changing rapid "do-it-yourself" DNA test - Microchip instead of genetics
DUBLIN, March 28, 2014 /PRNewswire/ -- Dublin - Research and Markets ( http://www.researchandmarkets.com/research/8zbxmj/investigation) has announced the addition of the
ChinaMarketResearchReports.com adds Latest Report on “Investigation Report on China Epoetin Alfa Market, 2009-2018” to its store. Dallas, TX (PRWEB) March
In recent years, non-hematopoietic effects of erythropoietin (EPO), via its binding to the EPO receptor in non-hematopoietic tissues, including cancerous tissues, has been reported by many different laboratories worldwide.
- A transitional zone between two communities containing the characteristic species of each.